Meeting
2018 ASCO Annual Meeting
Contribution of nationwide genome screening in Japan (LC-SCRUM-Japan) to the development of precision medicine for non-small cell lung cancer.
Authors
Takashi Seto
Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka, Japan
Takashi Seto , Shingo Matsumoto , Kiyotaka Yoh , Yutaka Fujiwara , Takuma Yokoyama , Kazumi Nishino , Terufumi Kato , Shunichi Sugawara , Masato Shingoji , Masahiro Kodani , Kadoaki Ohashi , Katsuya Tsuchihara , Koichi Goto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Metastatic Non–Small Cell Lung Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 9085)
DOI
10.1200/JCO.2018.36.15_suppl.9085
Abstract #
9085
Poster Bd #
408
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Impact of rapid multigene assays with short turnaround time (TAT) on the development of precision medicine for non-small cell lung cancer (NSCLC).
First Author: Shingo Matsumoto
Poster
2016 ASCO Annual Meeting
Development of nationwide genomic screening project (LC-SCRUM-Japan) contributing to the establishment of precision medicine in Japan.
First Author: Takuma Yokoyama
Poster
2020 ASCO Virtual Scientific Program
Establishment of the first international large-scale, genomic screening platform to identify patients with rare oncogene drivers in non-small cell lung cancer (NSCLC) in East Asia.
First Author: Shingo Matsumoto
Poster
2014 ASCO Annual Meeting
Next-generation sequencing (NGS) to identify actionable genomic alterations (GA) in “pan-negative” lung adenocarcinomas (ADC) from patients with no smoking or a light smoking (NS/LS) history.
First Author: Alexander E. Drilon